Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 25 Dec 2023
Additionally, in frontline settings, bispecific antibodies exhibit high response rates.
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
In 18 States, alcohol exclusion laws are still in effect.
2.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
3.
NIH research cuts leave cancer patient facing hard choice
4.
Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS
5.
healthy despite having advanced cancer.
1.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
2.
Seeing the Unseen: Examining Chancroid Through Images
3.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
4.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
5.
What Is A High MCV Level? Causes, Symptoms, And Treatment Options
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Navigating the Complexities of Ph Negative ALL - Part VIII
5.
Sickle Cell Disease Explained
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge